[title missed]

Corresponding author: chenxi, fuzhoucxi@163.com

DOI: 10.12201/bmr.202607.00029

•  

  Abstract: [abstract missed]

  Key words: ; ; ; ; 

  Submit time: 21 July 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Wang Huan, Ma Ying, Tian Jingnan, Lu Yi. Progress in the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Hypothyroidism from the Perspectives of Traditional Chinese and Western Medicine. 2025. doi: 10.12201/bmr.202505.00004

  叶妙淇, Liujianying, Xuyijiao, Wanglumin, Xiaxiaotong. Blood Biomarkers and VTE Risk in Cancer Patients Receiving ICIs. 2026. doi: 10.12201/bmr.202601.00053

  QIAN Yun. Adverse events associated with immune checkpoint inhibitors: clinical manifestations and mechanisms. 2025. doi: 10.12201/bmr.202502.00010

  Li Ying, Wang Xiaofei, Lu Shengwei, Dong Danni, Zhang Jingfeng, Zheng Jianjun. CT Findings and Clinical Features of checkpoint Inhibitor-related pneumonitis. 2024. doi: 10.12201/bmr.202407.00008

  guying. . 2025. doi: 10.12201/bmr.202506.00040

  RuanQingFa. . 2026. doi: 10.12201/bmr.202606.00046

  常丹阳, Fang Guizhen. . 2024. doi: 10.12201/bmr.202407.00007

  Research Progress on Integrated Traditional Chinese and Western Medicine for Chemotherapy-Induced Myelosuppression in Gastrointestinal Malignancies. 2025. doi: 10.12201/bmr.202506.00008

  Yuan Heqing, Shao Xiying. . 2025. doi: 10.12201/bmr.202504.00058

  Wang De, Huang Jun, Li Hai-xian, Long Fu-li. The Prevention and Treatment Effects of Integrated Traditional Chinese and Western Medicine on Primary Liver Cancer and Related Mechanisms. 2026. doi: 10.12201/bmr.202605.00085

• ID	Submit time	Number	Download
  1	2026-04-02	10.12201/bmr.202607.00029V1	Download

• Public  Anonymous  To author only Submit Comments